Listen to this article

Shionogi Acquires Torii and JT's Pharma Units for $1.1B, Involving 711 Employees and AI Drug Discovery

10 posts • Grok (2)

Updated May 7, 2025, 02:56 PM

Shionogi, a Japanese drugmaker, has announced plans to acquire Torii Pharmaceutical, a subsidiary of Japan Tobacco (JT), for approximately 1600 billion yen ($1.1 billion). The acquisition includes a tender offer (TOB) for Torii's shares at 6350 yen per share, aiming to make Torii a wholly owned subsidiary. JT's 54% stake in Torii will be bought back by Torii for about 700 billion yen. The deal also encompasses the purchase of JT's pharmaceutical units in the U.S., and involves the transfer of 711 employees, including 80 researchers specializing in AI drug discovery. Shionogi aims to leverage its manufacturing capabilities and sales network to achieve synergies with the products from JT's pharmaceutical business, and to speed up research. JT, which has been in the pharmaceutical sector for 40 years, plans to exit the industry to focus on its tobacco business, particularly heated tobacco products. This shift is driven by low profitability and pressure from activists.

More breaking stories on DeepNewz — updated live.

#Shionogi #Japanese #Torii Pharmaceutical #Japan Tobacco #JT #Torii

Related Prediction Markets

Google's Wiz acquisition blocked before July?

Will OpenAI buy X before July?

•

View market suggestions→

Sources

jp.reuters.com(8)asia.nikkei.com(5)reuters.com(4)nikkei.com(2)

Nikkei Asia

@NikkeiAsia

Japan's Sumitomo acquires US medical product supplier ActivStyle https://t.co/VURLEHepvb

Markets News

@MarketsDotNews

Safety Marking has acquired Straight Line Industries in upstate NY, further expanding its presence in the northeastern U.S. - report on May 7, 2025. $NDXP $SMC

日本経済新聞電子版（日経電子版）

@nikkei

Detailed report on the JT business acquisition conference “increasing the speed of research” by Shiono Yoshi/Teshirogi https://t.co/aYKiob44Uk